missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human GDAP1L1 (aa 89-148) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (97%), Rat (97%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-64101 (PA5-64101. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The ganglioside GD3 synthase causes cell differentiation with neurite sprouting when transfected into the mouse neuroblastoma cell line Neuro2a. After differentiation, the expression of several genes is upregulated, including one that encodes a protein termed ganglioside-induced differentiation-associated protein 1 (Gdap1). A similar gene was found in humans, and mutations in the human gene are associated with Charcot-Marie-Tooth type 4A disease. The protein encoded by this gene is similar in sequence to the human GDAP1 protein. Several transcript variants encoding different isoforms, as well as a noncoding transcript variant, have been found for this gene.
Specifications
Specifications
| Accession Number | Q96MZ0 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 78997 |
| Name | Human GDAP1L1 (aa 89-148) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | dJ881L22.1; dJ995J12.1.1; ganglioside induced differentiation associated protein 1 like 1; ganglioside induced differentiation associated protein 1-like 1; ganglioside induced differentiation associated protein 1-like 1; ganglioside-induced differentiation-associated protein 1-like 1; ganglioside-induced differentiation-associated protein 1-like 1; Gdap1l; GDAP1L1; GDAP1-L1 |
| Common Name | GDAP1L1 |
| Show More |